Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
SEC charges former Puma biotech exec with $1.1 million in insider trading
Puma Biotechnology Inc
Takeda farms out cancer drug alisertib to Puma Biotech -
Puma Biotechnology
Puma Biotech Strikes Deal to Develop and Market its Breast Cancer Drug in China - Los Angeles Business Journal
Why Puma Biotechnology Shares Dropped 17.7% This Week | The Motley Fool
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Puma Biotechnology and Bixink Therapeutics Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in South Korea | Business Wire